{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:57:12Z","timestamp":1762419432140,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.rgmxen.2023.04.015","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:20:48Z","timestamp":1697016048000},"page":"433-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia"],"prefix":"10.1016","volume":"88","author":[{"given":"A.","family":"Guti\u00e9rrez-Mac\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Barroso-Benayos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Burzako-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2023.04.015_bib0005","doi-asserted-by":"crossref","first-page":"104575","DOI":"10.1016\/j.ejmg.2022.104575","article-title":"European reference network for rare vascular diseases (VASCEM): when and how to use intravenous bevacizumab in hereditary haemorrhagic telangiectasia (HHT)?","volume":"65","author":"Dupuis-Girod","year":"2022","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.rgmxen.2023.04.015_bib0010","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s10620-017-4719-3","article-title":"Gastrointestinal manifestations of hereditary hemorrhagic telangiectasia (HHT): a systematic review of the literature","volume":"62","author":"Jackson","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.rgmxen.2023.04.015_bib0015","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.rgmxen.2023.04.015_bib0020","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.mayocp.2020.03.001","article-title":"Intravenous bevacizumab in hereditary hemorrhagic telangiectasia-related bleeding and high-output cardiac failure: significant interindividual variability in the need for maintenance therapy","volume":"95","author":"Albitar","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rgmxen.2023.04.015_bib0025","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0042-1743467","article-title":"Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: a practical, evidence-based guide for clinicians","volume":"48","author":"Al-Samkari","year":"2022","journal-title":"Semin Thromb Hemost"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X23001007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X23001007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:53:09Z","timestamp":1762419189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X23001007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2255534X23001007"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.04.015","relation":{},"ISSN":["2255-534X"],"issn-type":[{"type":"print","value":"2255-534X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2023.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2023.04.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Masson Doyma M\u00e9xico S.A. on behalf of Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda.","name":"copyright","label":"Copyright"}]}}